IDEAYA Biosciences — Fact Sheet (February 2026)

2 slides from IDEAYA Biosciences's fact sheet, Feb 17, 2026

Slide 1: IDEAYA Highlights: Improving Lives Through Transformative Precision Medicines
NASDAQ: IDYA IDEAYA Highlights February 2026 Breakthrough Science on transformative programs in precision medicine, including Synthetic Lethality – an emerging area of precision medicine Broad Pipeline of potential first-in-class precision medicine oncology programs with defined patient biomarkers I
Slide 2: IDEAYA Biosciences – Fact Sheet
IDEAYA Biosciences – Fact Sheet Founded 2015 on the thesis that Synthetic Lethality would emerge as a central focus of precision medicine oncology, with significant Pharma interest and the potential to develop first-in-class therapeutics for biomarker-defined cancer patient populations. Broad Pipeli